• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Brain+

Less than 1K followers
Overview
Investor consensus
All
Press releases
3rd party
ShowingAll content types

Regulatory press release23.03.2026, 13.36

Bankruptcy order issued for BRAIN+ A/S

Brain+
Regulatory press release19.03.2026, 13.59

BRAIN+ A/S to file for bankruptcy - 19 March 2026

Brain+
Regulatory press release12.03.2026, 15.12

Update on in-court restructuring proceedings - 12 March 2026

Brain+

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release05.03.2026, 13.20

Update on in-court restructuring proceedings - 5 March 2026

Brain+
Regulatory press release13.02.2026, 16.34

Update on in-court restructuring proceedings - 13 February 2026

Brain+
Regulatory press release04.02.2026, 17.36

Update on in-court restructuring proceedings - 4 February 2026

Brain+
Regulatory press release27.01.2026, 13.34

Correction: Update on in-court restructuring proceedings - 27 January 2026

Brain+
Regulatory press release27.01.2026, 13.10

Update on in-court restructuring proceedings - 27 January 2026

Brain+
Regulatory press release20.01.2026, 20.52

Notice of in-court restructuring proceedings of BRAIN+ A/S

Brain+
Regulatory press release20.01.2026, 10.07

Brain+ is seeking restructuring proceedings

Brain+
Press release08.01.2026, 22.29

Brain+ Investor Update – December 2025

Brain+
Press release04.12.2025, 12.46

Brain+ Investor Update - November

Brain+
Regulatory press release19.11.2025, 12.24

Brain+ A/S updates its financial guidance for 2025

Brain+
Press release06.11.2025, 15.13

Brain+ investor update — October

Brain+
Press release31.10.2025, 08.00

BRAIN+ UPDATES ITS COMMUNICATION POLICY AS THE COMPANY MOVES INTO A NEW COMMERCIALISATION PHASE

Brain+
Regulatory press release06.10.2025, 08.20

Brain+ appoints new Chief Financial Officer

Brain+
Press release24.09.2025, 08.36

Brain+ launches first Ayla NHS pilot with one of the UK’s largest primary care practices

Brain+
Press release16.09.2025, 09.21

Brain+ signs agreement with Agincare Homes – the fourth UK care home group to deploy effective dementia therapy with Ayla

Brain+
Regulatory press release15.09.2025, 11.41

The Chief Financial Officer to transition, replacement search has been initiated

Brain+
Press release04.09.2025, 11.58

Clinical pilot of Ayla based dementia therapy (CST) improves cognitive outcome by nearly 50% in care home residents

Brain+